1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Microbiome Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Human Microbiome Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 FMT
1.4.3 Microbiome Drugs
1.5 Market by Application
1.5.1 Global Human Microbiome Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 C. difficile
1.5.3 Crohn’s Disease
1.5.4 Inflammatory Bowel Disease
1.5.5 Diabetes
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Therapeutics Market Perspective (2015-2026)
2.2 Global Human Microbiome Therapeutics Growth Trends by Regions
2.2.1 Human Microbiome Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Human Microbiome Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Human Microbiome Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Human Microbiome Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Human Microbiome Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Therapeutics Players by Market Size
3.1.1 Global Top Human Microbiome Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Human Microbiome Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Human Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Human Microbiome Therapeutics Market Concentration Ratio
3.2.1 Global Human Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Human Microbiome Therapeutics Revenue in 2019
3.3 Human Microbiome Therapeutics Key Players Head office and Area Served
3.4 Key Players Human Microbiome Therapeutics Product Solution and Service
3.5 Date of Enter into Human Microbiome Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human Microbiome Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Human Microbiome Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Human Microbiome Therapeutics Market Size by Application (2015-2020)
5.2 Global Human Microbiome Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Human Microbiome Therapeutics Market Size (2015-2020)
6.2 Human Microbiome Therapeutics Key Players in North America (2019-2020)
6.3 North America Human Microbiome Therapeutics Market Size by Type (2015-2020)
6.4 North America Human Microbiome Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Human Microbiome Therapeutics Market Size (2015-2020)
7.2 Human Microbiome Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Human Microbiome Therapeutics Market Size by Type (2015-2020)
7.4 Europe Human Microbiome Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Human Microbiome Therapeutics Market Size (2015-2020)
8.2 Human Microbiome Therapeutics Key Players in China (2019-2020)
8.3 China Human Microbiome Therapeutics Market Size by Type (2015-2020)
8.4 China Human Microbiome Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Human Microbiome Therapeutics Market Size (2015-2020)
9.2 Human Microbiome Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Human Microbiome Therapeutics Market Size by Type (2015-2020)
9.4 Japan Human Microbiome Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Human Microbiome Therapeutics Market Size (2015-2020)
10.2 Human Microbiome Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Human Microbiome Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Human Microbiome Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Human Microbiome Therapeutics Market Size (2015-2020)
11.2 Human Microbiome Therapeutics Key Players in India (2019-2020)
11.3 India Human Microbiome Therapeutics Market Size by Type (2015-2020)
11.4 India Human Microbiome Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Human Microbiome Therapeutics Market Size (2015-2020)
12.2 Human Microbiome Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Human Microbiome Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Human Microbiome Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Enterome Bioscience
13.1.1 Enterome Bioscience Company Details
13.1.2 Enterome Bioscience Business Overview
13.1.3 Enterome Bioscience Human Microbiome Therapeutics Introduction
13.1.4 Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2015-2020))
13.1.5 Enterome Bioscience Recent Development
13.2 Rebiotix
13.2.1 Rebiotix Company Details
13.2.2 Rebiotix Business Overview
13.2.3 Rebiotix Human Microbiome Therapeutics Introduction
13.2.4 Rebiotix Revenue in Human Microbiome Therapeutics Business (2015-2020)
13.2.5 Rebiotix Recent Development
13.3 Seres Therapeutics
13.3.1 Seres Therapeutics Company Details
13.3.2 Seres Therapeutics Business Overview
13.3.3 Seres Therapeutics Human Microbiome Therapeutics Introduction
13.3.4 Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2015-2020)
13.3.5 Seres Therapeutics Recent Development
13.4 Vedanta Biosciences
13.4.1 Vedanta Biosciences Company Details
13.4.2 Vedanta Biosciences Business Overview
13.4.3 Vedanta Biosciences Human Microbiome Therapeutics Introduction
13.4.4 Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2015-2020)
13.4.5 Vedanta Biosciences Recent Development
13.5 Bristol-Myers Squibb
13.5.1 Bristol-Myers Squibb Company Details
13.5.2 Bristol-Myers Squibb Business Overview
13.5.3 Bristol-Myers Squibb Human Microbiome Therapeutics Introduction
13.5.4 Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2015-2020)
13.5.5 Bristol-Myers Squibb Recent Development
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Details
13.6.2 Johnson & Johnson Business Overview
13.6.3 Johnson & Johnson Human Microbiome Therapeutics Introduction
13.6.4 Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2015-2020)
13.6.5 Johnson & Johnson Recent Development
13.7 Takeda Pharmaceutical
13.7.1 Takeda Pharmaceutical Company Details
13.7.2 Takeda Pharmaceutical Business Overview
13.7.3 Takeda Pharmaceutical Human Microbiome Therapeutics Introduction
13.7.4 Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2015-2020)
13.7.5 Takeda Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Enterome Bioscience、Rebiotix、Seres Therapeutics、Vedanta Biosciences、Bristol-Myers Squibb、Johnson & Johnson、Takeda Pharmaceutical
【免責事項】
https://www.globalresearch.jp/disclaimer